Our portfolio company HAYA Therapeutics has been recognized by Labiotech.eu as one of the top 18 biotech startups in Switzerland, spotlighting its innovative approach to targeting non-coding RNAs to combat fibrotic diseases and age-related conditions: https://lnkd.in/gnPbAhQ As reported by The Financial Times, a groundbreaking anti-aging therapy that mimics regenerative processes seen in axolotl salamanders has shown promise in extending the lifespan of mice by 25%. Read more about the treatment that targets the pro-inflammatory protein IL-11: https://lnkd.in/guvdqyFH New hires at our portfolio companies: HAYA Therapeutics welcomes Eric Adam as their new COO, bringing his extensive experience from the pharmaceutical and diagnostics industries to support their growth and scientific exploration. Meanwhile, Auron Therapeutics, Inc. introduces Serge Messerlian to their board, enhancing their leadership as they advance their innovative cancer therapeutics platform. #ICYDK #ApolloVC #Lifespan #Healthspan #Longevity #VentureCapital
Apollo Health Ventures
Wagniskapital- und Private-Equity-Auftraggeber
Building Next Generation Companies To Enhance Healthy Lifespan
Info
Apollo Health Ventures is a transatlantic early stage Venture Capital firm actively co-founding and investing in transformative healthcare companies targeting age-related diseases and aging itself.
- Website
-
https://apollo.vc
Externer Link zu Apollo Health Ventures
- Branche
- Wagniskapital- und Private-Equity-Auftraggeber
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Berlin
- Art
- Privatunternehmen
- Gegründet
- 2016
Orte
-
Primär
Berlin, DE
-
Boston, US
Beschäftigte von Apollo Health Ventures
Updates
-
We are thrilled to announce another milestone for our portfolio company, Ochre Bio. Ochre Bio has entered into a multi-year data license agreement with GSK to advance the understanding and treatment of liver diseases. Ochre Bio is a biotech firm developing RNA-based therapies for chronic liver diseases. The company integrates machine learning, human data, in-house RNA chemistry, and live human donor liver testing. Read more about this partnership in their press release: https://lnkd.in/eeETgHV6 #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital
-
As seed investors early on, we are thrilled that our portfolio company HAYA Therapeutics has received the prestigious Andreas & Thomas Strüngmann Award, celebrating their advancements in developing targeted treatments for chronic diseases. This recognition highlights the groundbreaking advancements that HAYA is making in RNA technology, which aligns with Apollo Health Ventures’ mission to support companies at the forefront of scientific innovation. We are proud to be part of HAYA’s journey and look forward to witnessing their continued success in transforming healthcare. The award was established in honor of Andreas Strüngmann, M.D., and Thomas Strüngmann, Ph.D., who have significantly impacted the life sciences through their entrepreneurial achievements and visionary investments – such as their early investment in BioNTech. For a more in-depth look at HAYA’s innovative work and their recognition, check out the full story in Handelsblatt: https://lnkd.in/eJW4G9zn #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital
-
Apollo Health Ventures has been spotlighted by Michael Greve from Kizoo Ventures as one of the top five VCs to watch in the longevity and biotech space in a recent article in Gründerszene by Nina Anika Klotz: https://lnkd.in/ezQvtiEg A Science Magazine article explores how recent research highlights the potential of enhanced communication between organs to slow aging. By improving neural signals, this novel approach promises to extend healthspan and delay age-related deterioration: https://lnkd.in/eqNBw5Yi “How to invest in biotech” – The Financial Times reports on the resurgence of biotech investments, highlighting innovative treatments from dementia to diabetes. Read why the sector’s potential is immense: https://lnkd.in/efxPBiuP A new study in GeroScience by Springer Nature Group sheds light on the remarkable longevity of naked mole-rats, whose aging process defies conventional wisdom. This offers promising insights into how we might extend human health spans: https://lnkd.in/d3EBGaME #ICYDK #ApolloVC #Lifespan #Healthspan #Longevity #VentureCapital
-
Apollo Health Ventures hat dies direkt geteilt
Excited to share my recent appearance on the 'Making Sense of Science' podcast with Matt Fuchs by Upworthy Science! We discussed Apollo Health Ventures' pioneering work in developing therapeutics to enhance and extend healthy lifespans. During the episode, we explored the present and future of therapeutics aimed at increasing #healthspan, the benefits of certain lifestyle practices, and the best use of electronic wearables. I also shared insights on #rapamycin, including my personal views on whether to take it for longevity. If you're passionate about the future of biotech and medicine for healthy longevity, let's connect and explore potential collaborations! Tune in to the full conversation on Upworthy Science: https://lnkd.in/debryPjN #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital 🌟💡
-
We are honored to have been featured in the German newspaper Der Tagesspiegel’s coverage of the growing longevity movement, focusing on Berlin, as it hosted its first „Longevity-Week“. Jan Adams, our Venture Partner, shares insights on Berlin’s potential to lead Europe in longevity, emphasizing our strategic contributions to this sector. Let us know in the comments if you want us to send you a translation of the article, or read the full article here: https://lnkd.in/eUvz_a5U #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital
Das Geschäft mit dem langen Leben: Berlin auf dem Weg zur Longevity-Hauptstadt
tagesspiegel.de
-
Our portfolio company HAYA Therapeutics has been nominated as a finalist in the newly launched Andreas & Thomas Strüngmann Award which honors outstanding entrepreneurial talent and accomplishments in the field of life sciences: https://lnkd.in/dBvvTNKJ A recent study published in Nature Portfolio has shown the potential of rejuvenating the immune system to slow aging. Studies in mice show that revitalizing the immune system can invigorate multiple body organs, offering new ways to tackle age-related diseases: https://lnkd.in/dX-UnDFM Researchers at Penn State University have discovered new insights into the link between caloric restriction and aging. The study examined how reducing calorie intake affects telomere length, a key biomarker of aging: https://lnkd.in/eMEmSuug #ICYDK #ApolloVC #Lifespan #Healthspan #Longevity #VentureCapital
-
If you are in Porto today, come and see our Venture Partner, Christopher R. Shepard, as he holds a talk titled "Immune System Reconstitution by Regeneration of Thymus Function with Small Molecule Medicines." Presenting to researchers and students to share Thymus and T-cell biology advancements, the talk will focus on his work with our creation lab venture, ThymoFox (www.thymofox.com). Drop Christopher R. Shepard a message if you are in town and want to meet up. #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital
-
Meet us in San Diego at the BIO International Convention from June 3rd – 7th. Our Partner Jan Adams will explore new opportunities and collaborations at this biotech event, which hosts over 20,000 industry leaders globally and represents the full biotechnology ecosystem. Reach out if you are in town or let us know via email: [email protected] #BIO2024 #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital
-
Longevity investment hits $3.01 B according to Longevity.Technology’s 2023 annual investment report. This highlights the growing interest and resilience in the longevity industry, despite overall market challenges – with significant advancements expected in the future: https://lnkd.in/dsMeKQhN In a recent The Times article, Eric Schmidt, former CEO & Chairman of Google, discusses the transformative potential of biotechnology, emphasizing the critical intersection of AI and biotech, and the opportunity for biotech’s “ChatGPT moment,”: https://lnkd.in/g2EKGfC5 A study in Nature Portfolio Aging shows that reintroducing reprogramming transcription factors in aged mice enhances neuroblast production, restoring younger cellular profiles and improving brain function: https://lnkd.in/enMUYzsd Another study found that small extracellular vesicles from young mice can reverse aging-related declines in older mice by boosting mitochondrial energy metabolism, extending lifespan, improving physiological functions, and stimulating PGC-1α expression crucial for energy production: https://lnkd.in/eCkz4zxb #ICYDK #ApolloVC #Lifespan #Healthspan #Longevity #VentureCapital